Change - Announcement of Appointment::Appointment of Independent Non-Executive Director

Issuer & Securities

Issuer/ Manager
V2Y CORPORATION LTD.
Securities
V2Y CORPORATION LTD. - SGXE31442804 - V2Y
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Appointment
Date &Time of Broadcast
28-Jul-2023 19:56:16
Status
New
Announcement Sub Title
Appointment of Independent Non-Executive Director
Announcement Reference
SG230728OTHRUVDN
Submitted By (Co./ Ind. Name)
Ong Shen Chieh (Wang Shengjie)
Designation
Executive Director and Chief Executive Officer
Description (Please provide a detailed description of the event in the box below)
This announcement has been prepared by
the Company and its contents have been
reviewed by the Company's Sponsor,
RHT Capital Pte. Ltd. (the "Sponsor") for
compliance with the relevant rules of the
Singapore Exchange Securities Trading
Limited (the "SGX-ST").

This announcement has not been examined
or approved by the SGX-ST and the SGX-ST
assumes no responsibility for the contents of
this announcement, including the correctness
of any of the statements or opinions made or
reports contained in this announcement.

The contact person for the Sponsor is Mr.
Khong Choun Mun (Registered Professional,
RHT Capital Pte. Ltd.) at 36 Robinson Road,
#10-06 City House, Singapore 068877,
sponsor@rhtgoc.com.

Additional Details

Date Of Appointment
28/07/2023
Name Of Person
Seet Kah Wai (Xue Jiawei)
Age
43
Country Of Principal Residence
Singapore
The Board's comments on this appointment (including rationale, selection criteria, board diversity considerations, and the search and nomination process)
The Nominating Committee (the "NC") of the Company, having reviewed Mr Seet's educational background, professional qualifications and working experience, is of the view that Mr Seet has the necessary qualifications, working experience and ability to contribute to the Company, and thus recommended to the Board that Mr Seet be appointed as a Non-Executive and Independent Director.

In light of the reasons above and having considered the recommendation of the NC, the Board has approved the appointment of Mr Seet as a Non-Executive and Independent Director of the Company. Further to this, the Board considers Mr Seet to be independent for the purposes of Rule 704(7) of the Catalist Rules.
Whether appointment is executive, and if so, the area of responsibility
Non-Executive
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Independent Non-Executive Director and (with effect from 11 August 2023) Chairman of the AC, member of NC and RC.
Professional qualifications
Nanyang Technological University, Singapore, Bachelor of Accountancy, Second Class Honours (Upper Division), Institute of Singapore Chartered Accountants, Chartered Accountant of Singapore
Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/ or substantial shareholder of the listed issuer or any of its principal subsidiaries
Nil
Conflict of interests (including any competing business)
Nil
Working experience and occupation(s) during the past 10 years
2023 to present:
SVP, Finance, Growthwell Singapore Private Limited

2017 to 2023:
Chief Financial Officer, Asian Healthcare Specialists
Limited

2013 to 2017:
Deputy Chief Financial Officer, China Minzhong Food
Corporation Limited

2008 to 2013:
Financial Controller, China Minzhong Food Corporation
Limited

2004 to 2008:
Audit Senior Associate, PriceWaterHouseCoopers,
Singapore
Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6))
Yes
Shareholding interest in the listed issuer and its subsidiaries?
No
# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8).
Past (for the last 5 years)
Directorships
(1) Cornerstone Asia Health Pte. Ltd.

(2) Bobcheng Pte. Ltd.

(3) GS Medic Pte. Ltd.

(4) Ng Tay Meng G.I. HEP. Services Pte. Ltd.

(5) Ng Tay Meng Gastrointestinal and Liver Clinic Pte. Ltd.

(6) RSI Medical Pte. Ltd.

(7) Skin Consultancy Pte. Ltd.

(8) Uro Centre Pte. Ltd.

(9) Urology Novena Pte. Ltd.

(10) Urology Surgery Pte. Ltd.

(11) Salvia Ventures Pte. Ltd.

Other Principal Commitments
(1) Chief Financial Officer, Asian Healthcare Specialists Limited
Present
SVP, Finance, Growthwell Singapore Private Limited
(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?
No
(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency?
No
(c) Whether there is any unsatisfied judgment against him?
No
(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose?
No
(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach?
No
(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part?
No
(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust?
No
(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust?
No
(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity?
No
(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :-
(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or
No
(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or
No
(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or
No
(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust?
No
(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere?
No
Any prior experience as a director of an issuer listed on the Exchange?
No
If no, please state if the director has attended or will be attending training on the roles and responsibilities of a director of a listed issuer as prescribed by the Exchange
The Company will arrange for Mr Seet to attend the requisite training organised by the Singapore institute of Directors on the roles and responsibilities of a Director of a listed company to meet the mandatory training requirements under Rule 406(3)(a) of the Catalist Rules.